{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "Janus kinases", "Medicinal plant", "Nyctanthes arbor tristis", "Pharmacokinetics", "Rheumatoid arthritis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36083429", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "12"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.1007/s12010-022-04121-1"], "Journal": {"ISSN": "1559-0291", "JournalIssue": {"Volume": "195", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jan"}}, "Title": "Applied biochemistry and biotechnology", "ISOAbbreviation": "Appl Biochem Biotechnol"}, "ArticleTitle": "Bioactive Compounds from Nyctanthes arbor tristis Linn as Potential Inhibitors of Janus Kinases (JAKs) Involved in Rheumatoid Arthritis.", "Pagination": {"StartPage": "314", "EndPage": "330", "MedlinePgn": "314-330"}, "Abstract": {"AbstractText": ["Nyctanthes arbor tristis L (NAT) is one of the herbal plants whose parts are commonly used to treat diverse ailment including RA. Although the etiology of the autoimmune disorder RA is still unclear, actions of cytokines have been greatly associated with the mechanism of RA. Despite the huge development of drugs to combat this disorder, the search for alternative medicine is increasing due to the adverse effects of these synthetic drugs. Here, the ability of 30 selected bioactive compounds from the parts of NAT to bind effectively to target proteins of the Janus kinases as a potent inhibitor was predicted in an in silico manner through molecular docking procedure using Autodock 4.2.6 and their interactions visualized using Discovery Studio, followed by evaluating the physiochemical and ADMET properties of compounds of the lowest binding energy comparable to the reference drug baricitinib. Comparing the predicted target information with the standard drug baricitinib, 7 bioactive compounds may be potential lead drug for the treatment of RA owing to their lowest binding energy ranging from\u2009-\u20097.0\u00a0kcal/mol to\u2009-\u200910.49\u00a0kcal/mol and their pharmacokinetics properties. This can be used for further in vivo and in vitro studies to establish their potency as JAKs inhibitors to treat RA."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, 600048, Tamil Nadu, India."}], "LastName": "Mendie", "ForeName": "Love Edet", "Initials": "LE"}, {"Identifier": ["0000-0002-8150-7721"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, 600048, Tamil Nadu, India. hemalatha.sls@bsauniv.ac.in."}], "LastName": "Hemalatha", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Appl Biochem Biotechnol", "NlmUniqueID": "8208561", "ISSNLinking": "0273-2289"}, "ChemicalList": [{"RegistryNumber": "ISP4442I3Y", "NameOfSubstance": "baricitinib"}, {"RegistryNumber": "EC 2.7.10.2", "NameOfSubstance": "Janus Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Azetidines"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Janus Kinases"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Azetidines"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Arulmozhi, S., Matchado, M. S., Snijesh, V. P., Kumar, A., & Singh, S. (2019). An insight into anti-arthritic property OF C25H34O7 for rheumatoid arthritis using molecular modelling and molecular dynamics approach. Informatics in Medicine Unlocked, 16, 100145.", "ArticleIdList": ["10.1016/j.imu.2018.11.001"]}, {"Citation": "Rossol, M., Schubert, K., Meusch, U., Schulz, A., Biedermann, B., Grosche, J., Pierer, M., Scholz, R., Baerwald, C., Thiel, A., Hagen, S., & Wagner, U. (2013). Tumor necrosis factor receptor type I expression of CD4+ T cells in rheumatoid arthritis enables them to follow tumor necrosis factor gradients into the rheumatoid synovium. Arthritis and Rheumatism, 65(6), 1468\u20131476. https://doi.org/10.1002/art.37927", "ArticleIdList": ["10.1002/art.37927"]}, {"Citation": "Vos, T., Abajobir, A. A., Abate, K. H., et al. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries. The Lancet, 390(10100), 1211\u20131259.", "ArticleIdList": ["10.1016/S0140-6736(17)32154-2"]}, {"Citation": "McInnes, I. B., & Schett, G. (2011). The pathogenesis of rheumatoid arthritis. The New England Journal of Medicine, 365(23), 2205\u20132219. https://doi.org/10.1056/NEJMra1004965", "ArticleIdList": ["10.1056/NEJMra1004965"]}, {"Citation": "Cadena, J., Vinaccia, S., P\u00e9rez, A., Rico, M. I., Hinojosa, R., & Anaya, J. M. (2003). The impact of disease activity on the quality of life, mental health status, and family dysfunction in Colombian patients with rheumatoid arthritis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, 9(3), 142\u2013150. https://doi.org/10.1097/01.RHU.0000073434.59752.f3", "ArticleIdList": ["10.1097/01.RHU.0000073434.59752.f3"]}, {"Citation": "Jain, D., Udhwani, T., Sharma, S., Gandhe, A., Reddy, P. B., Nayarisseri, A., & Singh, S. K. (2019). Design of novel JAK3 inhibitors towards rheumatoid arthritis using molecular docking analysis. Bioinformation, 15(2), 68\u201378. https://doi.org/10.6026/97320630015068", "ArticleIdList": ["10.6026/97320630015068"]}, {"Citation": "Das, B., & Samanta, S. (2015). Molecular target and therapeutic aspects of rheumatoid arthritis: a review. Asian Journal of Pharmaceutical and Clinical Research, 8, 32\u201340."}, {"Citation": "Yamaoka, K., Saharinen, P., Pesu, M., Holt, V. E., 3rd., Silvennoinen, O., & O\u2019Shea, J. J. (2004). The Janus kinases (Jaks). Genome Biology, 5(12), 253. https://doi.org/10.1186/gb-2004-5-12-253", "ArticleIdList": ["10.1186/gb-2004-5-12-253"]}, {"Citation": "Sikorski, K., Czerwoniec, A., Bujnicki, J. M., Wesoly, J., & Bluyssen, H. A. (2011). STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFN\u03b3, TLR4 and IL-6 in vascular disease. Cytokine & Growth Factor Reviews, 22(4), 211\u2013219. https://doi.org/10.1016/j.cytogfr.2011.06.003", "ArticleIdList": ["10.1016/j.cytogfr.2011.06.003"]}, {"Citation": "Gillinder, K. R., Tuckey, H., Bell, C. C., Magor, G. W., Huang, S., Ilsley, M. D., & Perkins, A. C. (2017). Direct targets of pSTAT5 signalling in erythropoiesis. PLoS ONE, 12(7), e0180922. https://doi.org/10.1371/journal.pone.0180922", "ArticleIdList": ["10.1371/journal.pone.0180922"]}, {"Citation": "Harrington, R., Al Nokhatha, S. A., & Conway, R. (2020). JAK inhibitors in rheumatoid arthritis: An evidence-based review on the emerging clinical data. Journal of Inflammation Research, 13, 519\u2013531. https://doi.org/10.2147/JIR.S219586", "ArticleIdList": ["10.2147/JIR.S219586"]}, {"Citation": "Di, Y. M., Zhou, Z. W., Guang Li, C., & Zhou, S. F. (2011). Current and future therapeutic targets of rheumatoid arthritis. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 10(2), 92\u2013120.", "ArticleIdList": ["10.2174/187152111795508270"]}, {"Citation": "Gou, K. J., Zeng, R., Ren, X. D., Dou, Q. L., Yang, Q. B., Dong, Y., & Qu, Y. (2018). Anti-rheumatoid arthritis effects in adjuvant-induced arthritis in rats and molecular docking studies of Polygonumorientale L. extracts. Immunology Letters, 201, 59\u201369. https://doi.org/10.1016/j.imlet.2018.11.009", "ArticleIdList": ["10.1016/j.imlet.2018.11.009"]}, {"Citation": "Winthrop, K. L. (2017). The emerging safety profile of JAK inhibitors in rheumatic disease. Nature Reviews. Rheumatology, 13(5), 320. https://doi.org/10.1038/nrrheum.2017.51", "ArticleIdList": ["10.1038/nrrheum.2017.51"]}, {"Citation": "Shandhar, H. K., & Kaur, M. (2011). An update on Nyctanthes arbor-tristis Linn. Journal of Internationale Pharmaceutica Sciencia, 1, 77\u201386."}, {"Citation": "Agrawal, J., & Pal, A. (2013). Nyctanthesarbortristis Linn\u2014A critical ethnopharmacological review. Journal of Ethnopharmacology, 146, 645\u2013658.", "ArticleIdList": ["10.1016/j.jep.2013.01.024"]}, {"Citation": "Mendie, L. E., & Hemalatha, S. (2022). Molecular docking of phytochemicals targeting GFRs as therapeutic sites for cancer: An in silico study. Applied Biochemistry and Biotechnology, 194(1), 215\u2013231. https://doi.org/10.1007/s12010-021-03791-7", "ArticleIdList": ["10.1007/s12010-021-03791-7"]}, {"Citation": "Lutfiya, A. S., Priya, S., Manzoor, M. A. P., & Hemalatha, S. (2019). Molecular docking and interactions between vascular endothelial growth factor (VEGF) receptors and phytochemicals: An in-silico study. Biocatalysis and Agricultural Biotechnology, 22, 101424. https://doi.org/10.1016/j.bcab.2019.101424", "ArticleIdList": ["10.1016/j.bcab.2019.101424"]}, {"Citation": "Ghoreschi, K., Laurence, A., & O\u2019Shea, J. J. (2009). Janus kinases in immune cell signaling. Immunological reviews, 228(1), 273\u2013287. https://doi.org/10.1111/j.1600-065X.2008.00754.x", "ArticleIdList": ["10.1111/j.1600-065X.2008.00754.x"]}, {"Citation": "Babon, J. J., Lucet, I. S., Murphy, J. M., Nicola, N. A., & Varghese, L. N. (2014). The molecular regulation of Janus kinase (JAK) activation. The Biochemical Journal, 462(1), 1\u201313. https://doi.org/10.1042/BJ20140712", "ArticleIdList": ["10.1042/BJ20140712"]}, {"Citation": "Chen, X. P., & Du, G. H. (2007). Target validation: A door to drug discovery. Drug Discoveries & Therapeutics, 1(1), 23\u201329."}, {"Citation": "Du, X., Li, Y., Xia, Y. L., Ai, S. M., Liang, J., Sang, P., Ji, X. L., & Liu, S. Q. (2016). Insights into protein-ligand interactions: Mechanisms, models, and methods. International Journal of Molecular Sciences, 17(2), 144. https://doi.org/10.3390/ijms17020144", "ArticleIdList": ["10.3390/ijms17020144"]}, {"Citation": "Sarkar, B., Ullah, M. A., Islam, S. S., Rahman, M. H., & Araf, Y. (2021). Journal of Receptor and Signal Transduction Research, 41, 217\u2013233.", "ArticleIdList": ["10.1080/10799893.2020.1805628"]}, {"Citation": "Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615\u20132623. https://doi.org/10.1021/jm020017n", "ArticleIdList": ["10.1021/jm020017n"]}, {"Citation": "Radchenko, E. V., Dyabina, A. S., Palyulin, V. A., & Zefirov, N. S. (2016). Prediction of human intestinal absorption of drug compounds. Russian Chemical Bulletin, 65(2), 576\u2013580.", "ArticleIdList": ["10.1007/s11172-016-1340-0"]}, {"Citation": "Basant, N., Gupta, S., & Singh, K. P. (2016). Predicting human intestinal absorption of diverse chemicals using ensemble learning based QSAR modeling approaches. Computational Biology and Chemistry, 61, 178\u2013196. https://doi.org/10.1016/j.compbiolchem.2016.01.005", "ArticleIdList": ["10.1016/j.compbiolchem.2016.01.005"]}, {"Citation": "Wessel, M. D., Jurs, P. C., Tolan, J. W., & Muskal, S. M. (1998). Prediction of human intestinal absorption of drug compounds from molecular structure. Journal of Chemical Information and Computer Sciences, 38(4), 726\u2013735. https://doi.org/10.1021/ci980029a", "ArticleIdList": ["10.1021/ci980029a"]}, {"Citation": "Dong, J., Wang, N. N., Yao, Z. J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A. P., & Cao, D. S. (2018). ADMETlab: A platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. Journal of Cheminformatics, 10(1), 29. https://doi.org/10.1186/s13321-018-0283-x", "ArticleIdList": ["10.1186/s13321-018-0283-x"]}, {"Citation": "Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., Chen, X., Hou, T., & Cao, D. (2021). ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research, 49(W1), W5\u2013W14. https://doi.org/10.1093/nar/gkab255", "ArticleIdList": ["10.1093/nar/gkab255"]}, {"Citation": "Ji, D., Xu, M., Udenigwe, C. C., & Agyei, D. (2020). Physicochemical characterisation, molecular docking, and drug-likeness evaluation of hypotensive peptides encrypted in flaxseed proteome. Current research in food science, 3, 41\u201350. https://doi.org/10.1016/j.crfs.2020.03.001", "ArticleIdList": ["10.1016/j.crfs.2020.03.001"]}, {"Citation": "Sahin, S., & Benet, L. Z. (2008). The operational multiple dosing half-life: A key to defining drug accumulation in patients and to designing extended release dosage forms. Pharmaceutical Research, 25(12), 2869\u20132877. https://doi.org/10.1007/s11095-008-9787-9", "ArticleIdList": ["10.1007/s11095-008-9787-9"]}, {"Citation": "Aronov, A. M. (2005). Predictive in silico modeling for hERG channel blockers. Drug Discovery Today, 10(2), 149\u2013155. https://doi.org/10.1016/S1359-6446(04)03278-7", "ArticleIdList": ["10.1016/S1359-6446(04)03278-7"]}, {"Citation": "Krause, M. L., & Matteson, E. L. (2014). Perioperative management of the patient with rheumatoid arthritis. World Journal of Orthopedics, 5(3), 283\u2013291. https://doi.org/10.5312/wjo.v5.i3.283", "ArticleIdList": ["10.5312/wjo.v5.i3.283"]}, {"Citation": "Begum, S. M., Kalai, C., Benin, J., Raji, S., & Hemalatha, S. (2018). Gelidiella acerosa inhibits lung cancer proliferation. BMC Complementary and Alternative Medicine, 18, 104. https://doi.org/10.1186/s12906-018-2165-1", "ArticleIdList": ["10.1186/s12906-018-2165-1"]}, {"Citation": "Sai Nivetha, S., Ranjani, S., & Hemalatha, S. (2022). Synthesis and application of silver nanoparticles using Cissus quadrangularis. Inorganic and Nano-Metal Chemistry, 52(1), 82\u201389. https://doi.org/10.1080/24701556.2020.1862219", "ArticleIdList": ["10.1080/24701556.2020.1862219"]}, {"Citation": "Cargnin, S. T., & Gnoatto, S. B. (2017). Ursolic acid from apple pomace and traditional plants: A valuable triterpenoid with functional properties. Food Chemistry, 220, 477\u2013489. https://doi.org/10.1016/j.foodchem.2016.10.029", "ArticleIdList": ["10.1016/j.foodchem.2016.10.029"]}, {"Citation": "Zhang, F., Liu, Z., He, X., Li, Z., Shi, B., & Cai, F. (2020). \u03b2-Sitosterol-loaded solid lipid nanoparticles ameliorate complete Freund\u2019s adjuvant-induced arthritis in rats: Involvement of NF-\u043aB and HO-1/Nrf-2 pathway. Drug Delivery, 27(1), 1329\u20131341. https://doi.org/10.1080/10717544.2020.1818883", "ArticleIdList": ["10.1080/10717544.2020.1818883"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "28"}, {"Year": "2022", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "9", "Hour": "11", "Minute": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36083429", "10.1007/s12010-022-04121-1", "10.1007/s12010-022-04121-1"]}}], "PubmedBookArticle": []}